|
IDP-121 Clinical Trials
1 actively recruiting trial
Pipeline
Phase 1/2: 1
Top Sponsors
- IDP Discovery Pharma S.L.1
Indications
- Triple Hit Lymphoma1
- High Grade B-Cell Lymphoma, Not Otherwise Specified1
- Double Hit Lymphoma1
- Multiple Myeloma (MM)1
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.